Osmind builds clinical software and data infrastructure for mental health care providers, specializing in psychiatry clinics and clinics offering novel treatments such as ketamine and other neuromodulatory or psychedelic therapies. The platform combines electronic health record workflows, standardized outcome measurement, scheduling and billing integrations, and analytics to support clinical decision-making, outcomes tracking, and research across specialty psychiatric treatments.
Osmind LinkedIn following is increasing, signaling rising market interest, while its workforce is growing, indicating business expansion.
Osmind had 78 employees as of November 2, 2026. The number of employees increased by 0 (0.00%) week-over-week.
Osmind had 13,761 followers as of November 2, 2026. The number of followers increased by 26 (0.19%) week-over-week.
| Funding Date | Funding Round | Amount Raised | Post-Money Valuation |
|---|---|---|---|
| Jun 10, 2022 | Series B | $40.00M | ― |
| Investor Name | Funding Round |
|---|---|
| DFJ Growth | Series B |
A snapshot of private companies similar to Osmind, helping you discover and navigate related company profiles.



